Resultados da pesquisa - Yoshinori Ito
- A mostrar 1 - 20 resultados de 71
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
Profile of the JACC Study Por Akiko Tamakoshi, Takesumi Yoshimura, Yutaka Inaba, Yoshinori Ito, Yoshiyuki Watanabe, Katsuhiro Fukuda, Hiroyasu Iso
Publicado em 2005Artigo -
7
-
8
Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy Por Naoko Honma, Rie Horii, Yoshinori Ito, Shigehira Saji, Mamoun Younes, Takuji Iwase, Futoshi Akiyama
Publicado em 2015Artigo -
9
Stability of Frozen Serum Levels of Insulin-like Growth Factor-I, Insulin-like Growth Factor-II, Insulin-like Growth Factor Binding Protein-3, Transforming Growth Factorβ, Soluble... Por Yoshinori Ito, Kei Nakachi, Kazue Imai, Shuji Hashimoto, Yoshiyuki Watanabe, Yutaka Inaba, Akiko Tamakoshi, Takesumi Yoshimura
Publicado em 2005Artigo -
10
Postoperative Chemoradiotherapy After Local Resection for High-Risk T1 to T2 Low Rectal Cancer: Results of a Single-Arm, Multi-Institutional, Phase II Clinical Trial Por Takeshi Sasaki, Yoshinori Ito, Masayuki Ohue, Yukihide Kanemitsu, Takaya Kobatake, Masaaki Ito, Yoshihiro Moriya, Norio Saito
Publicado em 2017Artigo -
11
-
12
Accuracy of magnetic resonance imaging for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy: association with breast cancer subtype Por Takayo Fukuda, Rie Horii, Naoya Gomi, Yumi Miyagi, Shunji Takahashi, Yoshinori Ito, Futoshi Akiyama, Shinji Ohno, Takuji Iwase
Publicado em 2016Artigo -
13
-
14
A randomized Phase III trial of comparing two dose-fractionations stereotactic body radiotherapy (SBRT) for medically inoperable Stage IA non-small cell lung cancer or small lung l... Por Tomoki Kimura, Yasushi Nagata, Junko Eba, Shuichi Ozawa, Satoshi Ishikura, Taro Shibata, Yoshinori Ito, Masahiro Hiraoka, Yasumasa Nishimura
Publicado em 2016Editorial -
15
Subgroup analysis of Japanese patients in a Phase 3 study of atezolizumab in advanced triple-negative breast cancer (IMpassion130) Por Hiroji Iwata, Kenichi Inoue, Koji Kaneko, Yoshinori Ito, Koichiro Tsugawa, Ayumi Hasegawa, Shintaro Nakagawa, Hiroyasu Kuratomi, Kenji Tamura
Publicado em 2019Artigo -
16
-
17
Plasma Viral MicroRNA Profiles Reveal Potential Biomarkers for Chronic Active Epstein–Barr Virus Infection Por Yoshihiko Kawano, Seiko Iwata, Jun‐ichi Kawada, Kensei Gotoh, Michio Suzuki, Yuka Torii, Seiji Kojima, Hiroshi Kimura, Yoshinori Ito
Publicado em 2013Artigo -
18
mTOR Inhibitors Induce Cell-Cycle Arrest and Inhibit Tumor Growth in Epstein–Barr Virus–Associated T and Natural Killer Cell Lymphoma Cells Por Jun‐ichi Kawada, Yoshinori Ito, Seiko Iwata, Michio Suzuki, Yoshihiko Kawano, Tetsuhiro Kanazawa, Mohammed Nure Alam Siddiquey, Hiroshi Kimura
Publicado em 2014Artigo -
19
Efficient BMP2 gene transfer and bone formation of mesenchymal stem cells by a fiber-mutant adenoviral vector Por Hajime Tsuda, Takuro Wada, Yoshinori Ito, Hiroaki Uchida, Hironari Dehari, Kiminori Nakamura, Katsunori Sasaki, Masayoshi Kobune, Toshihiko Yamashita, Hirofumi Hamada
Publicado em 2003Artigo -
20
Phase III placebo-controlled, double-blind, randomized trial of pegfilgrastim to reduce the risk of febrile neutropenia in breast cancer patients receiving docetaxel/cyclophosphami... Por Yoshimasa Kosaka, Yoshiaki Rai, Norikazu Masuda, Toshimi Takano, Toshiaki Saeki, Seigo Nakamura, Ryutaro Shimazaki, Yoshinori Ito, Yutaka Tokuda, Kazuo Tamura
Publicado em 2015Artigo
Ferramentas de pesquisa:
Assuntos relacionados
Medicine
Internal medicine
Cancer
Biology
Immunology
Pathology
Oncology
Gene
Biochemistry
Breast cancer
Virus
Surgery
Virology
Genetics
Surgical oncology
Chemotherapy
Clinical endpoint
Radiation therapy
Cancer research
Colorectal cancer
Esophageal cancer
Family medicine
Guideline
Lymphoma
Alternative medicine
Cell biology
Clinical Practice
Clinical trial
Confidence interval
Endocrinology